Zebinix (eslicarbazepine acetate) has received market authorization as a once-daily monotherapy in adults with newly diagnosed partial-onset epilepsy.
Browsing: Epilepsy and seizure
Dr Deer discusses his career highlights, most memorable patient cases, and looks ahead at future challenges and trends in the field of neuromodulation.
Researchers observe clinically silent hippocampal seizures in two Alzheimer’s disease patients during sleep; a period critical for memory consolidation.
Eric Wasserman discusses tells us more about his work, uses for noninvasive brain stimulation, and the potential for neuromodulation in the treatment of neurological disorders.
Research demonstrates a daily dose of cannabidiol may help reduce seizures in children and adults suffering from Lennox- Gastaut syndrome (LGS).
Authors also claim that stress-reduction techniques could be an effective low-risk treatment for sufferers.
Mark Stewart shares his group’s work on developing an appropriate small animal model for SUDEP, a condition that presents a significant challenge to researchers, particularly given that it occurs rarely and under circumstances where physiological data are seldom available
A statistical approach has identified details of epilepsy brain networks that could lead to targeted treatments in the future.
Recent findings have indicated that bumetanide could be used to block the formation of aberrant neural connections in the brain that form after a convulsive epileptic seizure.
Serotonin receptor agonist discovered in a zebrafish model decreased seizure frequency in small pediatric clinical trial.